发明名称 Apelin fusion proteins and uses thereof
摘要 The invention provides a fusion protein or polypeptide comprising an apelin peptide fused to a multimerizing component. The invention also provides a fusion protein or polypeptide comprising an apelin peptide fused to an Fc domain, a fragment of an Fc domain, or a variant of an Fc domain. Apelin Fc-fusion polypeptides are capable of binding to the apelin receptor (APLNR). Apelin Fc-fusion polypeptides are capable of activating the APLNR and have improved pharmacokinetic properties compared to apelin peptides that are not fused to an Fc or an Fc fragment. Apelin Fc-fusion polypeptides are useful in diseases and conditions related to cardiovascular function, diabetes, cancer, obesity and other apelin-related conditions.
申请公布号 US9353163(B2) 申请公布日期 2016.05.31
申请号 US201414212753 申请日期 2014.03.14
申请人 Regeneron Pharmaceuticals, Inc. 发明人 Stevis Panayiotis;Murphy Andrew
分类号 A61K39/00;C12N5/07;C12N15/00;C12P21/08;C07H21/04;C07K14/435;C07K14/47;A61K38/00 主分类号 A61K39/00
代理机构 Alston & Bird LLP 代理人 Alston & Bird LLP ;Johnson Mary C.
主权项 1. A polypeptide comprising the amino acid sequence of SEQ ID NO: 2.
地址 Tarrytown NY US